[
    [
        {
            "time": "2019-11-01",
            "original_text": "有65家公司获重要股东增减持 延安必康已被连续减持134次",
            "features": {
                "keywords": [
                    "重要股东",
                    "增减持",
                    "延安必康",
                    "连续减持"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "有65家公司获重要股东增减持 延安必康已被连续减持134次",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-11-01",
            "original_text": "四大基金争夺冠军 谨防散户沦为基金砸盘牺牲者",
            "features": {
                "keywords": [
                    "基金",
                    "冠军",
                    "散户",
                    "砸盘"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "四大基金争夺冠军 谨防散户沦为基金砸盘牺牲者",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-11-01",
            "original_text": "云南白药(000538.SZ)截至10月末累计耗资2.45亿元回购0.26%股份",
            "features": {
                "keywords": [
                    "云南白药",
                    "回购",
                    "股份"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "云南白药(000538.SZ)截至10月末累计耗资2.45亿元回购0.26%股份",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-11-01",
            "original_text": "【IPO追踪】市场消息指中国抗体制药(3681-HK)国际配售获数倍认购",
            "features": {
                "keywords": [
                    "IPO",
                    "中国抗体制药",
                    "国际配售",
                    "认购"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【IPO追踪】市场消息指中国抗体制药(3681-HK)国际配售获数倍认购",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-11-01",
            "original_text": "牛市早报｜5G商用正式启动，美股全线大跌道指跌0.52%",
            "features": {
                "keywords": [
                    "5G",
                    "商用",
                    "美股",
                    "道指",
                    "下跌"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "牛市早报｜5G商用正式启动，美股全线大跌道指跌0.52%",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-11-01",
            "original_text": "巨丰数据赢｜北上资金流入力度加强 两股再现“价值洼地”",
            "features": {
                "keywords": [
                    "北上资金",
                    "流入",
                    "价值洼地"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "巨丰数据赢｜北上资金流入力度加强 两股再现“价值洼地”",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-11-01",
            "original_text": "医药生物板块四季度行情如何？多家机构看好走势",
            "features": {
                "keywords": [
                    "医药生物",
                    "四季度",
                    "机构",
                    "看好"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物板块四季度行情如何？多家机构看好走势",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]